Evidence map›Paper›PMID 39090779›Full record

ArticleHuman vaccines & immunotherapeutics2024

Immunogenicity and safety of an

Mayuresh M Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K Singh, Fernando Varnador, Sandra J Sivananthan, Robert Kinsey and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Mayuresh M AbhyankarDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
Feifan XuDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
Deborah ChavezSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Anna GoodroeSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Elda MendozaSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Christopher ChenSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Dhiraj K SinghSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Fernando VarnadorSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Sandra J SivananthanFormulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.ORCID 0009-0008-1707-7326
Robert KinseyFormulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.
William R LykinsFormulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.ORCID 0000-0001-5677-8733
Brynn M MurphyDepartment of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada.
Andrew R MartinDepartment of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada.
Mark A TomaiContract Employee for 3M Healthcare, Saint Paul, MN, USA.
Soutik GhosalDivision of Biostatistics, Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, VA, USA.
Corey CasperFormulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.ORCID 0000-0002-3609-661X
Karl PedersenProcess Development, TechLab Inc, Blacksburg, VA, USA.
William A PetriDivision of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
Christopher B FoxFormulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.ORCID 0000-0002-4644-2619

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
Role of CREM in Amebic Colitis and Inflammatory Bowel DiseaseR37AI026649 · NIAID · UNIVERSITY OF VIRGINIA · PI William A Petri · 2018 to 2026
$5.0M
NIAID NIH HHS HHSN272201800025CNIAID NIH HHS R37 AI026649NIH HHS P51 OD011133
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, IntranasalAntibodies, ProtozoanEntamoeba histolyticaEntamoebiasisInterferon-gammaLeukocytes, MononuclearLiposomesMacaca mulattaProtozoan VaccinesAdjuvants, ImmunologicAdjuvants, VaccineAnimalsAntigens, ProtozoanB-LymphocytesImmunity, HumoralImmunogenicity, VaccineAdjuvants, ImmunologicAdjuvants, VaccineAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin AImmunoglobulin GInterferon-gammaLiposomesProtozoan ProteinsProtozoan VaccinesamebiasisEntamoeba histolyticaintranasal deliverymucosal adjuvantrhesus macaque

Identifiers

PMID39090779
PMCPMC11296537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.